Literature DB >> 18584384

Drug use and risk among regular injecting drug users in Australia: does age make a difference?

Louisa Degenhardt1, Stuart A Kinner, Amanda Roxburgh, Emma Black, Raimondo Bruno, James Fetherston, Craig L Fry.   

Abstract

INTRODUCTION AND AIMS: To examine age-related differences in drug use and risk among regular injecting drug users (IDU) in Australia. DESIGN AND METHODS: Cross-sectional data from the 2006 Illicit Drug Reporting System were examined for age-related differences in demographic characteristics, drug use history and current use patterns and self-reported risk behaviours.
RESULTS: IDU under 25 years of age were more likely to have initiated injecting at a younger age, to identify as Aboriginal and/or Torres Strait Islander, and to be injecting daily or more often than their older counterparts. They reported more frequent heroin use in the preceding 6 months, and were more likely to report morphine as the first drug injected than were IDU aged 35 years or over. Younger IDU were also more likely to report providing used needles to others, engaging in recent property crime and drug dealing and arrest in the last year.
CONCLUSIONS: Younger IDU reported significantly different drug use patterns and higher rates of risk behaviours than their older counterparts. Treatment services need to ensure that harm and demand reduction services deliver messages to new cohorts of IDU, particularly given that their drug use patterns may be different to those of older users.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18584384     DOI: 10.1080/09595230701750643

Source DB:  PubMed          Journal:  Drug Alcohol Rev        ISSN: 0959-5236


  7 in total

1.  Trends in Injection Risk Behaviors among People Who Inject Drugs and the Impact of Harm Reduction Programs in Ukraine, 2007-2013.

Authors:  Iuliia Makarenko; D C Ompad; Y Sazonova; T Saliuk; J DeHovitz; L Gensburg
Journal:  J Urban Health       Date:  2017-02       Impact factor: 3.671

2.  Cross-border injection drug use and HIV and hepatitis C virus seropositivity among people who inject drugs in San Diego, California.

Authors:  Danielle Horyniak; Karla D Wagner; Richard F Armenta; Jazmine Cuevas-Mota; Erik Hendrickson; Richard S Garfein
Journal:  Int J Drug Policy       Date:  2017-07-03

3.  Harm Minimisation Drug Policy Implementation Qualities: Their Efficacy with Australian Needle and Syringe Program Providers and People Who Inject Drugs.

Authors:  Danielle Resiak; Elias Mpofu; Roderick Rothwell
Journal:  Healthcare (Basel)       Date:  2022-04-22

Review 4.  Providing comprehensive health services for young key populations: needs, barriers and gaps.

Authors:  Sinead Delany-Moretlwe; Frances M Cowan; Joanna Busza; Carolyn Bolton-Moore; Karen Kelley; Lee Fairlie
Journal:  J Int AIDS Soc       Date:  2015-02-26       Impact factor: 5.396

5.  Prevalence of HIV and other infections and correlates of needle and syringe sharing among people who inject drugs in Podgorica, Montenegro: a respondent-driven sampling survey.

Authors:  Dragan Lausevic; Senad Begic; Boban Mugosa; Natasa Terzic; Zoran Vratnica; Itana Labovic; Ivana Bozicevic
Journal:  Harm Reduct J       Date:  2015-02-28

6.  "Beyond Safer Injecting"-Health and Social Needs and Acceptance of Support among Clients of a Supervised Injecting Facility.

Authors:  Vendula Belackova; Edmund Silins; Allison M Salmon; Marianne Jauncey; Carolyn A Day
Journal:  Int J Environ Res Public Health       Date:  2019-06-07       Impact factor: 3.390

7.  Morphine Perinatal Exposure Induces Long-Lasting Negative Emotional States in Adult Offspring Rodents.

Authors:  Nair C F Castro; Izabelle S Silva; Sabrina C Cartágenes; Luanna M P Fernandes; Paula C Ribera; Mayara A Barros; Rui D Prediger; Enéas A Fontes-Júnior; Cristiane S F Maia
Journal:  Pharmaceutics       Date:  2021-12-24       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.